Suszczyk, D.; Skiba, W.; Zardzewiały, W.; Pawłowska, A.; Włodarczyk, K.; Polak, G.; Tarkowski, R.; Wertel, I.
Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis. Int. J. Mol. Sci. 2022, 23, 11607.
https://doi.org/10.3390/ijms231911607
AMA Style
Suszczyk D, Skiba W, Zardzewiały W, Pawłowska A, Włodarczyk K, Polak G, Tarkowski R, Wertel I.
Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis. International Journal of Molecular Sciences. 2022; 23(19):11607.
https://doi.org/10.3390/ijms231911607
Chicago/Turabian Style
Suszczyk, Dorota, Wiktoria Skiba, Witold Zardzewiały, Anna Pawłowska, Karolina Włodarczyk, Grzegorz Polak, Rafał Tarkowski, and Iwona Wertel.
2022. "Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis" International Journal of Molecular Sciences 23, no. 19: 11607.
https://doi.org/10.3390/ijms231911607
APA Style
Suszczyk, D., Skiba, W., Zardzewiały, W., Pawłowska, A., Włodarczyk, K., Polak, G., Tarkowski, R., & Wertel, I.
(2022). Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis. International Journal of Molecular Sciences, 23(19), 11607.
https://doi.org/10.3390/ijms231911607